Cargando…
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening
Pseudomonas aeruginosa is a leading cause of hospital-associated infections in the seriously ill, and the primary agent of chronic lung infections in cystic fibrosis patients. A major obstacle to effective control of P. aeruginosa infections is its intrinsic resistance to most antibiotic classes, wh...
Autores principales: | DiGiandomenico, Antonio, Warrener, Paul, Hamilton, Melissa, Guillard, Sandrine, Ravn, Peter, Minter, Ralph, Camara, Maria Margarita, Venkatraman, Vignesh, MacGill, Randall S., Lin, Jia, Wang, Qun, Keller, Ashley Elaine, Bonnell, Jessica C., Tomich, Mladen, Jermutus, Lutz, McCarthy, Michael P., Melnick, David A., Suzich, JoAnn A., Stover, C. Kendall |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405507/ https://www.ncbi.nlm.nih.gov/pubmed/22734046 http://dx.doi.org/10.1084/jem.20120033 |
Ejemplares similares
-
Anti-Psl Targeting of Pseudomonas aeruginosa Biofilms for Neutrophil-Mediated Disruption
por: Ray, Valerie A., et al.
Publicado: (2017) -
Publisher Correction: Anti-Psl Targeting of Pseudomonas aeruginosa Biofilms for Neutrophil-Mediated Disruption
por: Ray, Valerie A., et al.
Publicado: (2018) -
The advance of assembly of exopolysaccharide Psl biosynthesis machinery in Pseudomonas aeruginosa
por: Wu, Huijun, et al.
Publicado: (2019) -
Contribution of Pseudomonas aeruginosa Exopolysaccharides Pel and Psl to Wound Infections
por: Fleming, Derek, et al.
Publicado: (2022) -
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae
por: Pennini, Meghan E., et al.
Publicado: (2017)